>美国计算机辅助检测 (CAD) 市场，按产品类型（软件和服务）、成像方式（乳房成像、肺成像、肿瘤学和放射学、腹部和盆腔成像、牙科成像、心血管成像等）、应用（癌症、神经系统疾病、心血管疾病、肌肉骨骼疾病等）、购买方式（团购组织和个人）、最终用户（医院、诊断中心、研究中心和学术机构等）- 行业趋势和预测到 2031 年。
美国计算机辅助检测 (CAD) 市场分析和规模
推动市场扩张的关键因素是技术进步。CAD 系统在医疗领域的应用日益广泛，推动了市场的增长。此外，政府对 CAD 系统的举措将为市场开辟更多的商业潜力。然而，影响市场的主要制约因素是缺乏熟练的医疗专业人员。另一方面，人们对准确诊断的认识不断提高，预计将为市场增长创造机会。
Data Bridge Market Research 分析称，美国计算机辅助检测 (CAD) 市场规模预计将从 2023 年的 7.4232 亿美元增至 2031 年的 18.2695 亿美元，在 2024 年至 2031 年的预测期内，复合年增长率为 12.0%。
|
报告指标 |
细节 |
|
预测期 |
2024 至 2031 年 |
|
基准年 |
2023 |
|
历史岁月 |
2022（可定制 2016-2021） |
|
定量单位 |
收入（百万美元） |
|
涵盖的领域 |
产品类型（软件和服务）、成像方式（乳腺成像、肺成像、肿瘤学和放射学、腹部和盆腔成像、牙科成像、心血管成像等）、应用（癌症、神经系统疾病、心血管疾病、肌肉骨骼疾病等）、购买方式（团购组织和个人）、最终用户（医院、诊断中心、研究中心和学术机构等） |
|
覆盖国家 |
我们 |
|
涵盖的市场参与者 |
荷兰皇家飞利浦公司、富士胶片控股公司、佳能医疗系统公司、西门子医疗有限公司、Median Technologies、通用电气公司、Hologic 公司、iCAD 公司、EDDA Technology 公司和 Riverain Technologies 等 |
市场定义
“计算机辅助检测”(CAD) 一词描述了使用计算机算法和软件解释医学影像检查（例如 X 射线、CT 扫描和 MRI）的过程。CAD 系统会突出显示和标记图像中感兴趣的区域或可能的异常，以便放射科医生或其他医疗保健提供者可以进一步调查它们。这些系统分析图像中的模式、形状和密度，通过突出显示需要进一步检查的区域来提高诊断效率和准确性。CAD 是诊断过程中的有用工具，即使它不能取代人类的技能，也能帮助医疗专业人员理解和做出决策。
美国计算机辅助检测 (CAD) 市场动态
本节旨在了解市场驱动因素、优势、机遇、限制和挑战。以下内容将详细讨论所有这些内容：
驱动程序
- 计算机辅助检测 (CAD) 系统在医疗领域的应用日益增多
由于 CAD 系统在各个医学学科中的应用日益广泛，其市场也在不断发展壮大。CAD 系统广泛用于放射学，以识别乳房 X 光检查等图像中的复杂情况，但很快便扩展到许多其他医学专业。CAD 系统在放射学以外的专业领域（病理学、心脏病学、肿瘤学和神经病学）的使用也日益广泛，这表明它们在支持各个学科的医务人员方面具有适应性和有效性。CAD 能够为各种疾病提供早期识别、精确诊断和治疗计划，这正在彻底改变医疗保健程序。
CAD 应用的多样化提高了其市场潜力，吸引了更多寻求更精确、更高效诊断仪器的医疗专业人士。CAD 系统的应用率不断提高，证明了其在多个医学专业领域的有效性，推动了技术改进和市场扩张。
CAD 系统在各种医学专业中的采用和使用日益增多，凸显了它们对医疗保健的革命性影响。这些系统在各种专业领域的使用正在增长，因为它们有望促进更早、更准确的诊断、改善治疗结果和改善患者护理。因此，CAD 系统在医疗领域的应用日益增多，推动了市场增长。
- 与 CAD 相关的技术进步日益进步
医疗保健领域 CAD 市场增长和扩张的主要因素是技术进步。这些发展使 CAD 系统保持最新状态，并提高其适应性、精确度和诊断各种医疗疾病的能力。深度学习算法、机器学习和人工智能 (AI)的发展对于 CAD 系统的进步至关重要。这些发展使 CAD 软件能够以前所未有的速度和精度处理大量医学成像数据。这可以更准确、更可靠地识别 MRI、CT 扫描、X 射线和其他成像方式中的异常。
随着技术不断进步，CAD 系统将在检测、适应性和与医疗保健生态系统的集成方面取得进步。由于 CAD 行业不断应用技术改进，市场正在增长，这些改进具有革命性患者护理、提高诊断能力和影响医疗保健方向的巨大潜力。因此，不断进步的技术正在推动市场增长。
机会
- 美国先进的医疗基础设施
美国先进的医疗基础设施是创造市场重大机遇的一个因素。在美国，完善的医院和诊断中心网络，加上先进的医疗设施，为 CAD 技术的无缝集成提供了肥沃的土壤。强大的基础设施加速了 CAD 系统的采用，提高了医学成像和诊断的效率和准确性。
在美国，先进的医疗基础设施不仅为 CAD 的实施奠定了基础，也体现了利用尖端技术加强患者护理的承诺。这一承诺与医疗系统的技术准备相结合，创造了 CAD 蓬勃发展的环境，提供了先进的诊断能力，有助于更准确、更及时的医疗干预，预计将为市场增长创造机会。
克制/挑战
- 计算机辅助检测（CAD）系统成本高昂
许多医疗机构发现很难将 CAD 系统集成到其诊断工作流程中，因为 CAD 系统的购置和实施需要初始投资。CAD 系统通常需要医学成像专用硬件和软件。这些系统的前期成本可能很高，尤其是对于规模较小的医疗机构或预算较紧张的医疗机构而言。
总拥有成本包括初始支出之后的持续维护、更新和许可的额外费用。确保系统与最新发展同步并符合法律要求会增加成本。培训医护人员如何有效使用 CAD 系统并将其无缝集成到当前运营中需要更多时间和资源。初始部署和新功能或更新发布后的持续指导都需要与此培训相关的费用。为了使 CAD 系统能够跟上不断变化的医疗实践、技术突破和监管要求，需要定期更新和升级。硬件和软件更新是保持系统更新的额外成本。医务人员必须接受持续培训才能保持其对 CAD 技术的能力。持续培训计划需要员工教育和技能提升的成本。
医疗服务提供者，尤其是规模较小的诊所或资金有限的机构，由于成本高昂而不愿使用 CAD 系统。这一采用障碍限制了患者享受 CAD 系统更精确、更有效的诊断优势。医疗机构（尤其是规模较小的诊所或资源较少的诊所）的财务资源因维护费用的累积效应而紧张。因此，CAD 系统的高成本正在抑制市场增长。
美国计算机辅助检测 (CAD) 市场范围
美国计算机辅助检测 (CAD) 市场根据产品类型、成像方式、应用、购买方式和最终用户分为五个显著的细分市场。这些细分市场之间的增长将帮助您分析行业中的主要增长细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
产品类型
- 软件
- 服务
根据产品类型，美国计算机辅助检测 (CAD) 市场分为软件和服务。
成像方式
- 肿瘤学和放射学
- 乳腺成像
- 肺部成像
- 心血管成像
- 腹部和盆腔影像
- 牙科成像
- 其他的
根据成像方式，美国计算机辅助检测 (CAD) 市场细分为乳房成像、肺成像、肿瘤学和放射学、腹部和盆腔成像、牙科成像、心血管成像等。
应用
- 癌症
- 神经系统疾病
- 心血管疾病
- 肌肉骨骼疾病
- 其他的
根据应用，市场分为癌症、神经系统疾病、心血管疾病、肌肉骨骼疾病等。
购买方式
- 团购组织
- 个人
根据购买模式，美国计算机辅助检测 (CAD) 市场分为团购组织和个人。
最终用户
- 医院
- 诊断中心
- 研究机构和学术中心
- 其他的
根据最终用户，美国计算机辅助检测 (CAD) 市场分为医院、诊断中心、研究中心和学术机构等。
竞争格局和美国计算机辅助检测 (CAD) 市场份额分析
美国计算机辅助检测 (CAD) 市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、国家存在、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对市场的关注有关。
美国计算机辅助检测 (CAD) 市场的一些主要市场参与者包括荷兰皇家飞利浦公司、富士胶片控股公司、佳能医疗系统公司、西门子医疗有限公司、Median Technologies、通用电气公司、Hologic 公司、iCAD 公司、EDDA Technology 公司和 Riverain Technologies 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE U.S. COMPUTER AIDED DETECTION (CAD) MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 DBMR MARKET POSITION GRID
2.7 MULTIVARIATE MODELLING
2.8 TYPE LIFELINE CURVE
2.9 MARKET END USER COVERAGE GRID
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISING APPLICATION OF COMPUTER-AIDED DETECTION (CAD) SYSTEMS IN THE MEDICAL FIELD
5.1.2 INCREASING TECHNOLOGICAL ADVANCEMENTS ASSOCIATED WITH CAD
5.1.3 GOVERNMENT INITIATIVES FOR COMPUTER AIDED DETECTION (CAD) SYSTEMS
5.2 RESTRAINTS
5.2.1 HIGH COST OF COMPUTER AIDED DETECTION (CAD) SYSTEMS
5.2.2 STRICT GUIDELINES FOR COMPUTER AIDED DETECTION (CAD)
5.3 OPPORTUNITIES
5.3.1 ADVANCED HEALTHCARE INFRASTRUCTURE OF THE COUNTRIES
5.3.2 INCREASING AWARENESS REGARDING ACCURATE DIAGNOSIS
5.4 CHALLENGE
5.4.1 DEPENDENCY ON SKILLED MEDICAL PROFESSIONALS
6 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE
6.1 OVERVIEW
6.2 SOFTWARE
6.2.1 INTEGRATED CAD
6.2.1.1 CLOUD-BASED
6.2.1.2 ON-PREMISES
6.2.2 STANDALONE CAD
6.2.2.1 CLOUD-BASED
6.2.2.2 ON-PREMISES
6.3 SERVICES
7 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY
7.1 OVERVIEW
7.2 ONCOLOGY AND RADIATION
7.2.1 BY TYPE
7.2.1.1 ONCOLOGY CAD
7.2.1.2 RADIATION THERAPY PLANNING
7.2.2 BY TUMOR TYPE
7.2.2.1 MALIGNANT
7.2.2.2 BENIGN
7.2.3 BY PRODUCT TYPE
7.2.3.1 SOFTWARE
7.2.3.2 SERVICES
7.3 BREAST IMAGING
7.3.1 BY TYPE
7.3.1.1 MAMMOGRAPHY CAD
7.3.1.2 BREAST ULTRASOUND CAD
7.3.2 BY PRODUCT TYPE
7.3.2.1 SOFTWARE
7.3.2.2 SERVICES
7.4 LUNG IMAGING
7.4.1 BY TYPE
7.4.1.1 CHEST X-RAY CAD
7.4.1.2 CHEST CT CAD ON PULMONARY NODULES
7.4.2 BY NODULE SIZE
7.4.2.1 >4MM AND <5MM
7.4.2.2 >5MM
7.4.2.3 3 MM AND < 4MM
7.4.3 BY NODULE
7.4.3.1 PART SOLID NODULES
7.4.3.2 NON- SOLID NODULES
7.4.4 BY NODULE TYPE
7.4.4.1 JUXTAPLEURAL NODULES
7.4.4.2 ISOLATED NODULES
7.4.4.3 GROUND-GLASS NODULES
7.4.5 BY PRODUCT TYPE
7.4.5.1 SOFTWARE
7.4.5.2 SERVICES
7.5 CARDIOVASCULAR IMAGING
7.5.1 BY TYPE
7.5.1.1 CARDIAC CT CAD
7.5.1.2 CARDIAC MRI CAD
7.5.2 BY PRODUCT TYPE
7.5.2.1 SOFTWARE
7.5.2.2 SERVICES
7.6 ABDOMINAL AND PELVIC IMAGING
7.6.1 BY TYPE
7.6.1.1 GASTROINTESTINAL CAD
7.6.1.2 ABDOMINAL CT CAD
7.6.1.3 KIDNEY CAD
7.6.2 BY PRODUCT TYPE
7.6.2.1 SOFTWARE
7.6.2.2 SERVICES
7.6.2.3 DENTAL IMAGING
7.6.3 BY PRODUCT TYPE
7.6.3.1 SOFTWARE
7.6.3.2 SERVICES
7.7 OTHERS
8 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 CANCER
8.2.1 BREAST CANCER
8.2.2 COLORECTAL CANCER
8.2.3 LUNG CANCER
8.2.4 PROSTATE CANCER
8.2.5 LIVER CANCER
8.2.6 BONE CANCER
8.2.7 OTHERS
8.2.7.1 SOFTWARE
8.2.7.2 SERVICES
8.3 NEUROLOGICAL DISORDERS
8.3.1 MULTIPLE SCLEROSIS
8.3.2 STROKE
8.3.3 OTHERS
8.3.3.1 SOFTWARE
8.3.3.2 SERVICES
8.4 CARDIOVASCULAR DISEASES
8.4.1 CORONARY ARTERY DISEASE
8.4.2 CONGENITAL HEART DEFECTS
8.4.3 VALVULAR HEART DISEASE
8.4.4 OTHERS
8.4.4.1 SOFTWARE
8.4.4.2 SERVICES
8.5 MUSCULOSKELETAL DISEASES
8.5.1 OSTEOARTHRITIS
8.5.2 RHEUMATOID ARTHRITIS
8.5.3 JOINT DISORDERS
8.5.4 OTHERS
8.5.4.1 SOFTWARE
8.5.4.2 SERVICES
8.6 OTHERS
9 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE
9.1 OVERVIEW
9.2 GROUP PURCHASE ORGANIZATIONS
9.3 INDIVIDUAL
10 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.2.1 PRIVATE
10.2.2 PUBLIC
10.3 DIAGNOSTIC CENTERS
10.4 RESEARCH CENTERS & ACADEMIC INSTITUTES
10.5 OTHERS
11 COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: U.S.
12 SWOT ANALYSIS
13 COMPANY PROFILES
13.1 FUJIFILM HOLDINGS CORPORATION
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 PRODUCT PORTFOLIO
13.1.4 RECENT DEVELOPMENT
13.2 KONINKLIJKE PHILIPS N.V.
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 PRODUCT PORTFOLIO
13.2.4 RECENT DEVELOPMENT
13.3 CANON MEDICAL SYSTEMS CORPORATION
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 PRODUCT PORTFOLIO
13.3.4 RECENT DEVELOPMENT
13.4 SIEMENS HEALTHINEERS AG
13.4.1 COMPANY SNAPSHOT
13.4.2 REVENUE ANALYSIS
13.4.3 PRODUCT PORTFOLIO
13.4.4 RECENT DEVELOPMENT
13.5 MEDIAN TECHNOLOGIES.
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 PRODUCT PORTFOLIO
13.5.4 RECENT DEVELOPMENT
13.6 GENERAL ELECTRIC
13.6.1 COMPANY SNAPSHOT
13.6.2 REVENUE ANALYSIS
13.6.3 PRODUCT PORTFOLIO
13.6.4 RECENT DEVELOPMENT
13.7 HOLOGIC INC.
13.7.1 COMPANY SNAPSHOT
13.7.2 REVENUE ANALYSIS
13.7.3 PRODUCT PORTFOLIO
13.7.4 RECENT DEVELOPMENT
13.8 ICAD, INC.
13.8.1 COMPANY SNAPSHOT
13.8.2 REVENUE ANALYSIS
13.8.3 PRODUCT PORTFOLIO
13.8.4 RECENT DEVELOPMENT
13.9 EDDA TECHNOLOGY, INC.
13.9.1 COMPANY SNAPSHOT
13.9.2 PRODUCT PORTFOLIO
13.9.3 RECENT DEVELOPMENT
13.1 RIVERAIN TECHNOLOGIES
13.10.1 COMPANY SNAPSHOT
13.10.2 PRODUCT PORTFOLIO
13.10.3 RECENT DEVELOPMENT
14 QUESTIONNAIRE
15 RELATED REPORTS
表格列表
TABLE 1 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 2 U.S. SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 3 U.S. INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 4 U.S. STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 5 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)
TABLE 6 U.S. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 7 U.S. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 8 U.S. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 9 U.S. BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 10 U.S. BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 11 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 12 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)
TABLE 13 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)
TABLE 14 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)
TABLE 15 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 16 U.S. CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 17 U.S. CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 18 U.S. ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 19 U.S. ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 20 U.S. DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 21 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 22 U.S. CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 23 U.S. CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 24 U.S. NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 25 U.S. NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 26 U.S. CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 27 U.S. CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 28 U.S. MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 29 U.S. MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 30 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 31 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 32 U.S. HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
图片列表
FIGURE 1 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: SEGMENTATION
FIGURE 2 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: DATA TRIANGULATION
FIGURE 3 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: DROC ANALYSIS
FIGURE 4 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: COUNTRYWISE MARKET ANALYSIS
FIGURE 5 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: DBMR MARKET POSITION GRID
FIGURE 8 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: SEGMENTATION
FIGURE 10 INCREASING TECHNOLOGICAL ADVANCEMENTS ARE DRIVING THE GROWTH OF THE U.S. COMPUTER AIDED DETECTION (CAD) MARKET IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 11 SOFTWARE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE U.S. COMPUTER AIDED DETECTION (CAD) MARKET IN 2024 AND 2031
FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE U.S. COMPUTER AIDED DETECTION (CAD) MARKET
FIGURE 13 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, 2023
FIGURE 14 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, 2024-2031 (USD MILLION)
FIGURE 15 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, CAGR (2024-2031)
FIGURE 16 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 17 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, 2023
FIGURE 18 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, 2024-2031 (USD MILLION)
FIGURE 19 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, CAGR (2024-2031)
FIGURE 20 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, LIFELINE CURVE
FIGURE 21 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, 2023
FIGURE 22 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, 2024-2031 (USD MILLION)
FIGURE 23 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 24 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 25 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, 2023
FIGURE 26 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, 2024-2031 (USD MILLION)
FIGURE 27 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, CAGR (2024-2031)
FIGURE 28 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, LIFELINE CURVE
FIGURE 29 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, 2023
FIGURE 30 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, 2024-2031 (USD MILLION)
FIGURE 31 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, CAGR (2024-2031)
FIGURE 32 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, LIFELINE CURVE
FIGURE 33 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: COMPANY SHARE 2023 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
